Caricamento...
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart
Cardiovascular disease is the number one cause of morbidity and mortality in the United States. The most common manifestation of cardiovascular disease is myocardial infarction (MI), which can ultimately lead to congestive heart failure (CHF). Cell therap (cardiomyoplasty) is a new potential therape...
Salvato in:
| Pubblicato in: | J Cardiovasc Pharmacol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452997/ https://ncbi.nlm.nih.gov/pubmed/25658461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000183 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|